A METHOD FOR ASSESSING THE POTENTIAL RESPONSIVENESS OF A SUBJECT TO ANTI-CANCER DRUGS AFFECTING THE RAS SIGNAL TRANSDUCTION PATHWAY

Details for Australian Patent Application No. 2002366989 (hide)

Owner BIO GENE TECHNOLOGIES INC.

Inventors LURIA, Drorit; AVIGAD, Smadar

Pub. Number AU-A-2002366989

PCT Number PCT/IL02/01056

PCT Pub. Number WO2003/060161

Priority 147421 31.12.01 IL

Filing date 30 December 2002

Wipo publication date 30 July 2003

International Classifications

C12Q 001/68 Measuring or testing processes involving enzymes or micro-organisms - involving nucleic acids

Event Publications

4 September 2003 Application Open to Public Inspection

  Published as AU-A-2002366989

4 September 2003 Complete Application Filed

  Priority application(s): 147421 31.12.01 IL

16 September 2004 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(f)/See Reg. 8.3(3). Examination has not yet been requested or directed for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002366990-PROCESS FOR SENSING NUCLEIC ACIDS BY MEANS OF A CELL ARRAY CAPACITIVE SENSOR

2002366988-QUIET COOLING SYSTEM FOR A COMPUTER